Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1979 Oct;190(4):501–506. doi: 10.1097/00000658-197910000-00009

Calcium Infusion: A New Provocative Test for Insulinomas

Edwin L Kaplan, Arthur H Rubenstein, Richard Evans, Chen Hsen Lee, Peter Klementschitsch
PMCID: PMC1344516  PMID: 226013

Abstract

Calcium gluconate (10 mg Ca++/kg) was administered intravenously over a 2-hour period to 16 adult patients who were evaluated for hypoglycemia. In nine of ten patients with benign or malignant insulinomas (eight proven at operation, and two with positive chemical tests and angiographic localization awaiting operation), significant hypoglycemia and hyperinsulinemia occurred within 60 to 90 minutes after the start of the calcium infusion. Serum proinsulin and Cpeptide concentrations increased at the time of the calciuminduced hyperinsulinemia in several patients in whom these parameters were studied. The one individual who did not respond to the calcium infusion was found to have a benign insulinoma. His basal glucose/insulin ratio of 0.64 was the lowest of the insulinoma group and thus his failure to respond to calcium may indicate that his tumor was secreting maximally at the time of the infusion. Following successful removal of the insulinoma, calcium infusion did not result in changes in serum glucose or insulin concentrations (tested in five patients). In contrast, neither a patient with pathologically documented islet cell hyperplasia, five others with reactive, fupctional or drug-induced hypoglycemia, nor four healthy volunteers showed any changes in circulating glucose or insulin levels while receiving calcium intravenously. Calcium infusion is a safe, rapid and effective provocative test for the diagnosis of insulin-secreting, islet cell tumors of the pancreas.

Full text

PDF
501

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Creutzfeldt W., Arnold R., Creutzfeldt C., Deuticke U., Frerichs H., Track N. S. Biochemical and morphological investigations of 30 human insulinomas. Correlation between the tumour content of insulin and proinsulin-like components and the histological and ultrastructural appearance. Diabetologia. 1973 Jun;9(3):217–231. doi: 10.1007/BF01219786. [DOI] [PubMed] [Google Scholar]
  2. Deftos L. J. Radioimmunoassay for calcitonin in medullary thyroid carcinoma. JAMA. 1974 Jan 28;227(4):403–406. [PubMed] [Google Scholar]
  3. Fajans S. S., Floyd J. C., Jr, Knopf R. F., Rull J., Guntsche E. M., Conn J. W. Benzothiadiazine suppression of insulin release from normal and abnormal islet tissue in man. J Clin Invest. 1966 Apr;45(4):481–492. doi: 10.1172/JCI105362. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Gaeke R. F., Kaplan E. L., Rubenstein A., Starr J., Burke G. Insulin and proinsulin release during calcium infusion in a patient with islet-cell tumor. Metabolism. 1975 Sep;24(9):1029–1034. doi: 10.1016/0026-0495(75)90096-7. [DOI] [PubMed] [Google Scholar]
  5. HILL J. B., KESSLER G. An automated determination of glucose utilizing a glucose oxidase-peroxidase system. J Lab Clin Med. 1961 Jun;57:970–980. [PubMed] [Google Scholar]
  6. Horwitz D. L., Starr J. I., Mako M. E., Blackard W. G., Rubenstein A. H. Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood. J Clin Invest. 1975 Jun;55(6):1278–1283. doi: 10.1172/JCI108047. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kaplan E. L., Jaffe B. M., Peskin G. W. A new provocative test for the diagnosis of the carcinoid syndrome. Am J Surg. 1972 Feb;123(2):173–179. doi: 10.1016/0002-9610(72)90329-7. [DOI] [PubMed] [Google Scholar]
  8. Malaisse W. J., Pipeleers D. G., Mahy M. The stimulus-secretion coupling of glucose-induced insulin release. XII. Effects of diazoxide and gliclazide upon 45 calcium efflux from perifused islets. Diabetologia. 1973 Feb;9(1):1–5. doi: 10.1007/BF01225992. [DOI] [PubMed] [Google Scholar]
  9. Passaro E., Jr, Basso N., Walsh J. H. Calcium challenge in the Zollinger-Ellison syndrome. Surgery. 1972 Jul;72(1):60–67. [PubMed] [Google Scholar]
  10. Porte D., Jr, Graber A. L., Kuzuya T., Williams R. H. The effect of epinephrine on immunoreactive insulin levels in man. J Clin Invest. 1966 Feb;45(2):228–236. doi: 10.1172/JCI105335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Roy B. K., Abuid J., Wendorff H., Nitiyanant W., DeRobertis F. R., Field J. B. Insulin release in response to calcium in the diagnosis of insulinoma. Metabolism. 1979 Mar;28(3):246–252. doi: 10.1016/0026-0495(79)90071-4. [DOI] [PubMed] [Google Scholar]
  12. Whipple A. O., Frantz V. K. ADENOMA OF ISLET CELLS WITH HYPERINSULINISM: A REVIEW. Ann Surg. 1935 Jun;101(6):1299–1335. doi: 10.1097/00000658-193506000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES